FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2120289695> ?p ?o ?g. }

• W2120289695 endingPage "1443" @default.
• W2120289695 startingPage "1431" @default.
• W2120289695 abstract "Ezetimibe, a cholesterol-absorption inhibitor, reduces levels of low-density lipoprotein (LDL) cholesterol when added to statin treatment. However, the effect of ezetimibe on the progression of atherosclerosis remains unknown.We conducted a double-blind, randomized, 24-month trial comparing the effects of daily therapy with 80 mg of simvastatin either with placebo or with 10 mg of ezetimibe in 720 patients with familial hypercholesterolemia. Patients underwent B-mode ultrasonography to assess the intima-media thickness of the walls of the carotid and femoral arteries. The primary outcome measure was the change in the mean carotid-artery intima-media thickness, which was defined as the average of the means of the far-wall intima-media thickness of the right and left common carotid arteries, carotid bulbs, and internal carotid arteries.The primary outcome, the mean (+/-SE) change in the carotid-artery intima-media thickness, was 0.0058+/-0.0037 mm in the simvastatin-only group and 0.0111+/-0.0038 mm in the simvastatin-plus-ezetimibe (combined-therapy) group (P=0.29). Secondary outcomes (consisting of other variables regarding the intima-media thickness of the carotid and femoral arteries) did not differ significantly between the two groups. At the end of the study, the mean (+/-SD) LDL cholesterol level was 192.7+/-60.3 mg per deciliter (4.98+/-1.56 mmol per liter) in the simvastatin group and 141.3+/-52.6 mg per deciliter (3.65+/-1.36 mmol per liter) in the combined-therapy group (a between-group difference of 16.5%, P<0.01). The differences between the two groups in reductions in levels of triglycerides and C-reactive protein were 6.6% and 25.7%, respectively, with greater reductions in the combined-therapy group (P<0.01 for both comparisons). Side-effect and safety profiles were similar in the two groups.In patients with familial hypercholesterolemia, combined therapy with ezetimibe and simvastatin did not result in a significant difference in changes in intima-media thickness, as compared with simvastatin alone, despite decreases in levels of LDL cholesterol and C-reactive protein. (ClinicalTrials.gov number, NCT00552097 [ClinicalTrials.gov].)." @default.
• W2120289695 created "2016-06-24" @default.
• W2120289695 creator A5023301942 @default.
• W2120289695 creator A5029936998 @default.
• W2120289695 creator A5041480846 @default.
• W2120289695 creator A5049272753 @default.
• W2120289695 creator A5051056050 @default.
• W2120289695 creator A5062651514 @default.
• W2120289695 creator A5063763204 @default.
• W2120289695 creator A5072544302 @default.
• W2120289695 creator A5073320977 @default.
• W2120289695 creator A5077848934 @default.
• W2120289695 creator A5081557648 @default.
• W2120289695 creator A5081601973 @default.
• W2120289695 creator A5084834521 @default.
• W2120289695 creator A5086800836 @default.
• W2120289695 creator A5090781778 @default.
• W2120289695 date "2008-04-03" @default.
• W2120289695 modified "2023-10-17" @default.
• W2120289695 title "Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia" @default.
• W2120289695 cites W1504536459 @default.
• W2120289695 cites W1966564237 @default.
• W2120289695 cites W1974919082 @default.
• W2120289695 cites W1976358806 @default.
• W2120289695 cites W1987507883 @default.
• W2120289695 cites W2002817706 @default.
• W2120289695 cites W2037832608 @default.
• W2120289695 cites W2057867780 @default.
• W2120289695 cites W2058331351 @default.
• W2120289695 cites W2073693827 @default.
• W2120289695 cites W2100800328 @default.
• W2120289695 cites W2111385165 @default.
• W2120289695 cites W2116416944 @default.
• W2120289695 cites W2118959703 @default.
• W2120289695 cites W2122146058 @default.
• W2120289695 cites W2122975632 @default.
• W2120289695 cites W2123936150 @default.
• W2120289695 cites W2126708809 @default.
• W2120289695 cites W2130869061 @default.
• W2120289695 cites W2131334142 @default.
• W2120289695 cites W2132262454 @default.
• W2120289695 cites W2132725727 @default.
• W2120289695 cites W2139168645 @default.
• W2120289695 cites W2141210634 @default.
• W2120289695 cites W2142283630 @default.
• W2120289695 cites W2142435775 @default.
• W2120289695 cites W2147346175 @default.
• W2120289695 cites W2147971195 @default.
• W2120289695 cites W2156900995 @default.
• W2120289695 cites W2159449551 @default.
• W2120289695 cites W2162922521 @default.
• W2120289695 cites W2169033201 @default.
• W2120289695 cites W2331959986 @default.
• W2120289695 cites W424467158 @default.
• W2120289695 doi "https://doi.org/10.1056/nejmoa0800742" @default.
• W2120289695 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18677795" @default.
• W2120289695 hasPublicationYear "2008" @default.
• W2120289695 type Work @default.
• W2120289695 sameAs 2120289695 @default.
• W2120289695 citedByCount "1156" @default.
• W2120289695 countsByYear W21202896952012 @default.
• W2120289695 countsByYear W21202896952013 @default.
• W2120289695 countsByYear W21202896952014 @default.
• W2120289695 countsByYear W21202896952015 @default.
• W2120289695 countsByYear W21202896952016 @default.
• W2120289695 countsByYear W21202896952017 @default.
• W2120289695 countsByYear W21202896952018 @default.
• W2120289695 countsByYear W21202896952019 @default.
• W2120289695 countsByYear W21202896952020 @default.
• W2120289695 countsByYear W21202896952021 @default.
• W2120289695 countsByYear W21202896952022 @default.
• W2120289695 countsByYear W21202896952023 @default.
• W2120289695 crossrefType "journal-article" @default.
• W2120289695 hasAuthorship W2120289695A5023301942 @default.
• W2120289695 hasAuthorship W2120289695A5029936998 @default.
• W2120289695 hasAuthorship W2120289695A5041480846 @default.
• W2120289695 hasAuthorship W2120289695A5049272753 @default.
• W2120289695 hasAuthorship W2120289695A5051056050 @default.
• W2120289695 hasAuthorship W2120289695A5062651514 @default.
• W2120289695 hasAuthorship W2120289695A5063763204 @default.
• W2120289695 hasAuthorship W2120289695A5072544302 @default.
• W2120289695 hasAuthorship W2120289695A5073320977 @default.
• W2120289695 hasAuthorship W2120289695A5077848934 @default.
• W2120289695 hasAuthorship W2120289695A5081557648 @default.
• W2120289695 hasAuthorship W2120289695A5081601973 @default.
• W2120289695 hasAuthorship W2120289695A5084834521 @default.
• W2120289695 hasAuthorship W2120289695A5086800836 @default.
• W2120289695 hasAuthorship W2120289695A5090781778 @default.
• W2120289695 hasBestOaLocation W21202896951 @default.
• W2120289695 hasConcept C126322002 @default.
• W2120289695 hasConcept C126894567 @default.
• W2120289695 hasConcept C142724271 @default.
• W2120289695 hasConcept C164705383 @default.
• W2120289695 hasConcept C176674119 @default.
• W2120289695 hasConcept C204787440 @default.
• W2120289695 hasConcept C27081682 @default.
• W2120289695 hasConcept C2776329913 @default.
• W2120289695 hasConcept C2776820930 @default.

• next